Skip to main content
Fresenius SE & Co. KGaA logo

Fresenius SE & Co. KGaA — Investor Relations & Filings

Ticker · FRE ISIN · DE0005785604 LEI · XDFJ0CYCOO1FXRFTQS51 F Human health and social work activities
Open in API
Filings indexed 1,398 across all filing types
Latest filing 2019-01-21 Investor Presentation
Country DE Germany
Listing F FRE

About Fresenius SE & Co. KGaA

https://www.fresenius.com/

Fresenius SE & Co. KGaA is a global healthcare company that provides system-critical products and services for leading therapies for the care of critically and chronically ill patients. The company's portfolio encompasses a wide range of products and services for dialysis, hospitals, and outpatient medical care. Key offerings include intravenously administered generic drugs, biopharmaceuticals, biosimilars, clinical nutrition, and infusion therapies. Additionally, the company operates a large network of private hospitals and outpatient centers. Through its strategic investment in Fresenius Medical Care, it is a leading global provider of products and services for individuals with renal diseases.

Recent filings

Filing Released Lang Actions
Kepler Cheuvreux 18th German Corporate Conference
Investor Presentation Classification · 98% confidence The document is a presentation titled "18th German Corporate Conference GCC" and contains detailed slides covering company performance metrics, segment breakdowns (Fresenius Medical Care, Kabi, Helios, Vamed), financial outlooks for FY/18, Q3/18 highlights, and current topics like litigation updates (Akorn suit) and growth initiatives. The structure, use of charts, financial guidance tables, and forward-looking statements are characteristic of an Investor Presentation (IP) delivered at a conference, rather than a formal regulatory filing like a 10-K or a brief Earnings Release (ER). Since it is a detailed presentation for investors, the classification is Investor Presentation (IP).
2019-01-21 English
Commerzbank German Investment Seminar
Investor Presentation Classification · 98% confidence The document is titled "Commerzbank German Investment Seminar" and contains extensive slides detailing financial performance, segment breakdowns (Fresenius Medical Care, Kabi, Helios), financial outlooks, guidance for FY/18, and updates on current topics like legal proceedings (Akorn suit) and product development (Biosimilars). The content structure, including charts, tables with guidance figures, and segment analysis, is characteristic of an Investor Presentation (IP) or a detailed presentation given at an investment conference. It is not a formal regulatory filing like a 10-K, nor is it a brief earnings release (ER). Given the depth and presentation format, Investor Presentation (IP) is the most appropriate classification.
2019-01-14 English
DGAP-DD: Fresenius SE & Co. KGaA english
Director's Dealing Classification · 100% confidence The document explicitly contains the header "Directors’ Dealings" and details transactions made by a person discharging managerial responsibilities (Dr. Kurt Bock, Member of the administrative or supervisory body). This directly corresponds to the definition of Director's Dealing, which is classified under the code DIRS.
2018-12-20 English
Declaration of Conformity of Fresenius SE & Co. KGaA as of December 20, 2018
Governance Information Classification · 99% confidence The document is explicitly titled 'Declaration by the Management Board... on the German Corporate Governance Code pursuant to Section 161 German Stock Corporation Act'. This document details compliance (or non-compliance) with specific recommendations of the German Corporate Governance Code, referencing fiscal years and management compensation structures. This content directly aligns with the definition of Governance Information (CGR), which covers internal rules, board structure, and governance practices, often including compliance statements related to codes like the German Corporate Governance Code.
2018-12-20 English
Entsprechenserklärung der Fresenius SE & Co. KGaA vom 20. Dezember 2018
Governance Information Classification · 99% confidence The document is titled "Erklärung des Vorstands der persönlich haftenden Gesellschafterin der Fresenius SE & Co. KGaA, der Fresenius Management SE, und des Aufsichtsrats der Fresenius SE & Co. KGaA zum Deutschen Corporate Governance Kodex gemäß § 161 AktG". This explicitly states it is a declaration regarding the German Corporate Governance Code, which is a key component of corporate governance reporting. The content details compliance or deviations from specific recommendations (Kodex-Nummern) related to executive compensation (Vergütung), board composition, and age limits. This type of declaration is standard for Governance Information reports, aligning perfectly with the definition for 'Governance Information' (CGR). It is not an Annual Report (10-K), an Audit Report (AR), or a Remuneration Report (DEF 14A), but rather a statement *about* governance compliance.
2018-12-20 German
DGAP-DD: Fresenius SE & Co. KGaA english
Director's Dealing Classification · 100% confidence The document is explicitly titled 'Directors’ Dealings' and contains detailed tables reporting transactions (Acquisition) by a 'person discharging managerial responsibilities' (Dr. Dieter Schenk, Member of the administrative or supervisory body) in the company's shares. This directly matches the definition for Director's Dealing (DIRS). The presence of DGAP headers suggests it is a regulatory disclosure, but the content is specific to insider trading.
2018-12-12 English

Browse filings by year

31 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.